Wildfire smoke exposure and early childhood respiratory health: a study of prescription claims data

被引:8
|
作者
Dhingra, Radhika [1 ,2 ]
Keeler, Corinna [3 ]
Staley, Brooke S. S. [3 ]
Jardel, Hanna V. V. [3 ,4 ]
Ward-Caviness, Cavin [4 ]
Rebuli, Meghan E. E. [5 ,6 ]
Xi, Yuzhi [1 ]
Rappazzo, Kristen [4 ]
Hernandez, Michelle [5 ]
Chelminski, Ann N. N. [4 ]
Jaspers, Ilona [5 ,6 ]
Rappold, Ana G. G. [4 ]
机构
[1] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, 135 Dauer Dr,CB 7431, Chapel Hill, NC 27599 USA
[2] East Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA
[3] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
[4] United States Environm Protect Agcy, Ctr Publ Hlth & Environm Assessment, Durham, NC USA
[5] Univ North Carolina Chapel Hill, Sch Med, Dept Pediat, Chapel Hill, NC USA
[6] Univ North Carolina Chapel Hill, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA
关键词
Wildfire; Wildfire smoke; Smoke exposure; Prenatal; Perinatal; Childhood respiratory disease; Prescription claims; SOUTHERN CALIFORNIA WILDFIRES; FINE PARTICULATE MATTER; AIR-POLLUTION; LUNG-FUNCTION; HOSPITAL ADMISSIONS; RISK-FACTOR; WOOD SMOKE; CHILDREN; BIRTH; FIRE;
D O I
10.1186/s12940-023-00998-5
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Wildfire smoke is associated with short-term respiratory outcomes including asthma exacerbation in children. As investigations into developmental wildfire smoke exposure on children's longer-term respiratory health are sparse, we investigated associations between developmental wildfire smoke exposure and first use of respiratory medications. Prescription claims from IBM MarketScan Commercial Claims and Encounters database were linked with wildfire smoke plume data from NASA satellites based on Metropolitan Statistical Area (MSA). A retrospective cohort of live infants (2010-2016) born into MSAs in six western states (U.S.A.), having prescription insurance, and whose birthdate was estimable from claims data was constructed (N = 184,703); of these, gestational age was estimated for 113,154 infants. The residential MSA, gestational age, and birthdate were used to estimate average weekly smoke exposure days (smoke-day) for each developmental period: three trimesters, and two sequential 12-week periods post-birth. Medications treating respiratory tract inflammation were classified using active ingredient and mode of administration into three categories:: 'upper respiratory', 'lower respiratory', 'systemic anti-inflammatory'. To evaluate associations between wildfire smoke exposure and medication usage, Cox models associating smoke-days with first observed prescription of each medication category were adjusted for infant sex, birth-season, and birthyear with a random intercept for MSA. Smoke exposure during postnatal periods was associated with earlier first use of upper respiratory medications (1-12 weeks: hazard ratio (HR) = 1.094 per 1-day increase in average weekly smoke-day, 95%CI: (1.005,1.191); 13-24 weeks: HR = 1.108, 95%CI: (1.016,1.209)). Protective associations were observed during gestational windows for both lower respiratory and systemic anti-inflammatory medications; it is possible that these associations may be a consequence of live-birth bias. These findings suggest wildfire smoke exposure during early postnatal developmental periods impact subsequent early life respiratory health.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Urine Cotinine As A Marker Of Environmental Tobacco Smoke Exposure In Recurrent Respiratory Symptoms Of Early Childhood
    Maatta, A. M.
    Huovinen, A. E.
    Kotaniemi-Syrjanen, A.
    Malmstrom, K.
    Malmberg, L. P.
    Pelkonen, A. S.
    Makela, M. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [22] Association of tobacco smoke exposure and respiratory syncitial virus infection with airways reactivity in early childhood
    Adler, A
    Ngo, L
    Tager, IB
    PEDIATRIC PULMONOLOGY, 2001, 32 (06) : 418 - 427
  • [23] Is Early Life Exposure to Coal Mine Fire Smoke Associated with Childhood Respiratory, Atopic and Infective Illnesses?
    Shao, J.
    Zosky, G. R.
    Wheeler, A. J.
    Dharmage, S.
    Dalton, M.
    Williamson, G. J.
    O'Sullivan, T.
    Chappell, K.
    Johnston, F. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [24] Childhood exposure to environmental tobacco smoke and chronic respiratory symptoms in non-smoking adults: The Singapore Chinese Health Study
    David, GL
    Koh, WP
    Lee, HP
    Yu, MC
    London, SJ
    THORAX, 2005, 60 (12) : 1052 - 1058
  • [25] Respiratory health effects of exposure to environmental tobacco smoke
    Chan-Yeung, M
    Dimich-Ward, H
    RESPIROLOGY, 2003, 8 (02) : 131 - 139
  • [26] Fetal exposure to pregnancy complications and respiratory health in childhood: A longitudinal study
    Pesce, Giancarlo
    Marcon, Alessandro
    Marchetti, Pierpaolo
    Calciano, Lucia
    Guarda, Linda
    Ricci, Paolo
    Pironi, Vanda
    De Marco, Roberto
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [27] Exposure to smoke from simulated wildfire worsens ocular surface health and symptoms
    Jaiswal, Sukanya
    Golebiowski, Blanka
    Porter, Meagan
    Duong, Ha T.
    Madigan, Michele C.
    Johnston, Fay
    Jalbert, Isabelle
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [28] Wildfire smoke exposure and human health: Significant gaps in research for a growing public health issue
    Black, Carolyn
    Tesfaigzi, Yohannes
    Bassein, Jed A.
    Miller, Lisa A.
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2017, 55 : 186 - 195
  • [29] Pregnancy exposure to air pollution and early childhood respiratory health in the Norwegian Mother and Child Cohort Study (MoBa)
    Madsen, Christian
    Haberg, Siri Eldevik
    Magnus, Maria C.
    Aamodt, Geir
    Stigum, Hein
    London, Stephanie J.
    Nystad, Wenche
    Nafstad, Per
    BMJ OPEN, 2017, 7 (12):
  • [30] Duration of therapy with metoclopramide: a prescription claims data study
    Kaplan, Sigal
    Staffa, Judy A.
    Dal Pan, Gerald J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (08) : 878 - 881